Octagam (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Octagam, is an immunoglobulin presented as a sterile solution for intravenous use. It is used to replace missing antibodies and to modulate immune responses in patients with immune deficiencies and certain autoimmune conditions. GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Octagam is an immunoglobulin therapy that acts on disorders of the immune system.

- Primary immunodeficiency diseases: provides replacement antibodies to reduce infection risk. - Chronic inflammatory demyelinating polyneuropathy (CIDP): helps improve muscle strength and functional ability. - Multifocal motor neuropathy (MMN): reduces weakness and improves motor function. - Immune thrombocytopenia (ITP) refractory to other treatments: increases platelet counts. - Kawasaki disease with coronary artery involvement: lowers inflammation and risk of aneurysm formation.

Adverse reactions to Octagam vary in frequency and severity.

Common Side Effects: - Headache - Fever - Chills - Nausea - Fatigue - Mild infusion‑related erythema

Serious or Rare Side Effects: - Anaphylaxis - Acute hemolytic anemia - Thromboembolic events - Renal failure (acute kidney injury) - Severe aseptic meningitis - Transfusion‑related acute lung injury (TRALI)

Octagam should be administered under medical supervision with attention to patient‑specific risk factors.

- Assess renal function: evaluate baseline creatinine and adjust infusion rate if needed. - Monitor for thrombotic risk: consider patient history of clotting disorders before infusion. - Screen for IgA deficiency: patients with anti‑IgA antibodies may develop severe reactions. - Adjust infusion rate: slower rates reduce the likelihood of systemic reactions. - Use aseptic technique: ensure sterile handling to prevent contamination. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Octagam may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Live vaccines: concurrent use can diminish vaccine effectiveness and increase adverse events. - High‑dose aspirin or anticoagulants: may raise bleeding risk during infusion.

Moderate Interactions (Monitor Closely): - Immunosuppressants (e.g., cyclophosphamide, azathioprine): may enhance immunomodulatory effects. - Corticosteroids: can affect infusion‑related reactions. - Diuretics: monitor fluid balance during high‑volume infusions. - ACE inhibitors: watch for hypotensive episodes. - Rituximab: combined therapy may increase infection susceptibility.